Combined cytomorphologic and immunophenotypic analysis in the diagnostic workup of lymphomatous effusions.
OBJECTIVE
To analyze the results of cytomorphology and immunophenotyping in 54 patients with lymphomatous effusions.


METHODS
We report the results of cytomorphology and immunophenotyping in 54 patients with lymphomatous effusions. Twenty-three of the 54 had a previous diagnosis of NHL. In the remaining 31 patients, lymphomatous involvement was clinically suspected.


RESULTS
Thirty-three lymphomatous effusions were positive for involvement by NHL. Twenty-one of these 33 patients (64%) had a previous diagnosis of NHL. Of the remaining 12 patients with newly diagnosed NHL, 11 had high grade lymphoma, and one had follicular center lymphoma. Twenty effusions were considered to be reactive; only two of these patients had NHL. One effusion revealed involvement by a previously unknown carcinoma. We observed seven false negative results if only one of both methods was considered. A high grade NHL was not diagnosed by immunophenotyping in one case, and six cases of low grade NHL could not be detected by cytomorphology. The combined strategy of cytomorphology and immunophenotyping had a sensitivity of 100% and specificity of 100% in our study, confirmed by follow-up studies.


CONCLUSIONS
Both methods have shown difficulties in the examination of lymphomatous effusions. Cytomorphology has problems distinguishing reactive effusions from low grade NHL. The detection of high grade NHL by immunophenotyping is difficult. However, both methods together offer the advantage of dual staining ability and are most helpful in distinguishing clonal lymphomatous from reactive effusions.
Bangerter
M
M
Departments of Medicine I and III, University of Ulm, Robert-Koch-Strasse 8, D-89081 Ulm, Germany. markus.bangerter@medizin.uni-ulm.de
Hildebrand
A
A
Griesshammer
M
M
D001202:Ascitic Fluid / Q000473:pathology; D003581:Cytodiagnosis; D005260:Female; D006801:Humans; D016130:Immunophenotyping / Q000379:methods*; D008228:Lymphoma, Non-Hodgkin / Q000145:classification / Q000175:diagnosis* / Q000473:pathology; D008297:Male; D016066:Pleural Effusion, Malignant / Q000145:classification / Q000175:diagnosis* / Q000473:pathology; D012189:Retrospective Studies